Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status

A case control study

Daniel P. Howsmon, James Adams, Uwe Kruger, Elizabeth Geis, Eva Gehn, Juergen Hahn

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Biomarkers promise biomolecular explanations as well as reliable diagnostics, stratification, and treatment strategies that have the potential to help mitigate the effects of disorders. While no reliable biomarker has yet been found for autism spectrum disorder (ASD), fatty acids have been investigated as potential biomarkers because of their association with brain development and neural functions. However, the ability of fatty acids to classify individuals with ASD from age/gender-matched neurotypical (NEU) peers has largely been ignored in favor of investigating population-level differences. Contrary to existing work, this classification task between ASD and NEU cohorts is the main focus of this work. The data presented herein suggest that fatty acids do not allow for classification at the individual level.

Original languageEnglish (US)
Article number12
JournalBiomarker Research
Volume6
Issue number1
DOIs
StatePublished - Mar 14 2018

Fingerprint

Biomarkers
Case-Control Studies
Fatty Acids
Erythrocytes
Aptitude
Brain
Association reactions
Population
Autism Spectrum Disorder
Therapeutics

Keywords

  • Autism spectrum disorder
  • Diagnostic biomarkers
  • Fatty acids
  • Multivariate statistical analysis

ASJC Scopus subject areas

  • Molecular Medicine
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status : A case control study. / Howsmon, Daniel P.; Adams, James; Kruger, Uwe; Geis, Elizabeth; Gehn, Eva; Hahn, Juergen.

In: Biomarker Research, Vol. 6, No. 1, 12, 14.03.2018.

Research output: Contribution to journalArticle

Howsmon, Daniel P. ; Adams, James ; Kruger, Uwe ; Geis, Elizabeth ; Gehn, Eva ; Hahn, Juergen. / Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status : A case control study. In: Biomarker Research. 2018 ; Vol. 6, No. 1.
@article{dc1f15b78dda4245a78d6320602f626a,
title = "Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status: A case control study",
abstract = "Biomarkers promise biomolecular explanations as well as reliable diagnostics, stratification, and treatment strategies that have the potential to help mitigate the effects of disorders. While no reliable biomarker has yet been found for autism spectrum disorder (ASD), fatty acids have been investigated as potential biomarkers because of their association with brain development and neural functions. However, the ability of fatty acids to classify individuals with ASD from age/gender-matched neurotypical (NEU) peers has largely been ignored in favor of investigating population-level differences. Contrary to existing work, this classification task between ASD and NEU cohorts is the main focus of this work. The data presented herein suggest that fatty acids do not allow for classification at the individual level.",
keywords = "Autism spectrum disorder, Diagnostic biomarkers, Fatty acids, Multivariate statistical analysis",
author = "Howsmon, {Daniel P.} and James Adams and Uwe Kruger and Elizabeth Geis and Eva Gehn and Juergen Hahn",
year = "2018",
month = "3",
day = "14",
doi = "10.1186/s40364-018-0125-z",
language = "English (US)",
volume = "6",
journal = "Biomarker Research",
issn = "2050-7771",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Erythrocyte fatty acid profiles in children are not predictive of autism spectrum disorder status

T2 - A case control study

AU - Howsmon, Daniel P.

AU - Adams, James

AU - Kruger, Uwe

AU - Geis, Elizabeth

AU - Gehn, Eva

AU - Hahn, Juergen

PY - 2018/3/14

Y1 - 2018/3/14

N2 - Biomarkers promise biomolecular explanations as well as reliable diagnostics, stratification, and treatment strategies that have the potential to help mitigate the effects of disorders. While no reliable biomarker has yet been found for autism spectrum disorder (ASD), fatty acids have been investigated as potential biomarkers because of their association with brain development and neural functions. However, the ability of fatty acids to classify individuals with ASD from age/gender-matched neurotypical (NEU) peers has largely been ignored in favor of investigating population-level differences. Contrary to existing work, this classification task between ASD and NEU cohorts is the main focus of this work. The data presented herein suggest that fatty acids do not allow for classification at the individual level.

AB - Biomarkers promise biomolecular explanations as well as reliable diagnostics, stratification, and treatment strategies that have the potential to help mitigate the effects of disorders. While no reliable biomarker has yet been found for autism spectrum disorder (ASD), fatty acids have been investigated as potential biomarkers because of their association with brain development and neural functions. However, the ability of fatty acids to classify individuals with ASD from age/gender-matched neurotypical (NEU) peers has largely been ignored in favor of investigating population-level differences. Contrary to existing work, this classification task between ASD and NEU cohorts is the main focus of this work. The data presented herein suggest that fatty acids do not allow for classification at the individual level.

KW - Autism spectrum disorder

KW - Diagnostic biomarkers

KW - Fatty acids

KW - Multivariate statistical analysis

UR - http://www.scopus.com/inward/record.url?scp=85050134108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050134108&partnerID=8YFLogxK

U2 - 10.1186/s40364-018-0125-z

DO - 10.1186/s40364-018-0125-z

M3 - Article

VL - 6

JO - Biomarker Research

JF - Biomarker Research

SN - 2050-7771

IS - 1

M1 - 12

ER -